David Ovalle

Author's posts

On the streets, opioids sometimes more potent than fentanyl: nitazenes

The novel opioids can complicate overdose revivals and addiction treatment.

As high court weighs Purdue bankruptcy, opioid settlement divides victims

A controversial aspect of the Purdue Pharma bankruptcy plan shields the owners from future lawsuits in exchange for the family’s contributing up to $6 billion.

China vows to crack down on fentanyl chemicals. The impact is unclear.

Policy experts remain skeptical that China’s pledge will make a lasting dent in the global supply chain for illicit drugs.

The hunt quickens for vaccines and antibody therapies against opioids

The concept has long tantalized scientists: harnessing antibodies to block the dangerous effects of heroin, cocaine and nicotine.

CBD, delta-8, THCA: Texas hemp shop raid highlights legal, safety issues

Hemp itself is not intoxicating but can generate a high when converted to certain forms.

Sober homes promised help and shelter. Some delivered fraud, officials say.

More than 200 providers in Arizona have been suspended from the Medicaid program.

Philadelphia council bans safe-injection sites in most of the city

The vote underscores broader tensions over the concept of such facilities.

Kroger grocery chain to pay $1.2 billion to settle opioid lawsuits

The money adds to more than $50 billion in settlements obtained by state and local governments.

Narcan is now for sale without a prescription. Here’s what to know.

The nasal spray reverses opioid overdoses. More than 110,000 people are believed to have died of drug poisonings last year, many from synthetic opioids.

Possible easing of marijuana restrictions could have major implications

The drug could gain wider acceptance as a medical treatment and pot businesses could see their bottom line boosted.